Sign in
Taking people in United StatesPhase 3

Comparing bumetanide and furosemide water pills in hospitalized adults with cirrhosis

Compares bumetanide with furosemide for fluid removal in hospitalized adults with cirrhosis.

Key facts

Who runs it
Stacy Johnson
Where
Salt Lake City, United StatesSee the site
Trial code
Registry title
Bumetanide vs. Furosemide in Cirrhosis
Status
Recruiting
Phase
Phase 3
People taking part
500 people, planned
Started
3 Jun 2026
Expected to end
31 Mar 2029
Type of study
Interventional, 2 groups
Treatments tested
  • Bumetanide
  • Furosemide
Record updated
16 June 2026

Who can take part

The trial is looking for adults with liver cirrhosis who are admitted to hospital and need a water pill (diuretic) for fluid build-up. It compares bumetanide with furosemide.

Age
18 Years and older
Sex
All
Disease stage
Liver cirrhosis, in hospital with too much fluid in the body (volume overload).
Earlier treatment
A doctor must have ordered bumetanide or furosemide within 24 hours of arriving at the hospital.
Main reasons for not taking part
  • Allergy to bumetanide or furosemide
  • Reasons a diuretic cannot be given, such as active bleeding, suspected hepatorenal syndrome (kidney failure caused by liver disease) or low blood pressure
  • Being in prison or in police custody
  • Diuretic ordered for a reason other than fluid build-up, such as high potassium
  • Not admitted, or not expected to be admitted, to a hospital bed
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • History of liver cirrhosis
  • Clinician placed an order for bumetanide or furosemide in electronic health record within 24 hours of presentation to the hospital

Who cannot take part

  • Diuretic ordered for purpose other than volume overload (e.g. hyperkalemia, continuation of home medication without clinical signs of volume overload)
  • Allergy to bumetanide or furosemide
  • Contraindication to diuretic administration (e.g. active bleeding, clinical suspicion of hepatorenal syndrome, hypotension)
  • Incarcerated or in custody of law enforcement
  • Inpatient admission not anticipated
  • Not admitted to an inpatient hospital bed following initial evaluation in the emergency department

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Cirrhosis

This trial is currently available in United States.

  • University of Utah HospitalSalt Lake City, United StatesContact: Andrea T White, PhDTaking people

About the trial

What the trial wants to find out

Patients with cirrhosis are frequently hospitalized due to an acute decompensation of their liver disease including bleeding, jaundice, encephalopathy, and volume overload. Volume overload is associated with increased mortality from acute hypoxic respiratory failure, hemorrhage from esophageal varices, and spontaneous bacterial peritonitis.

Read full original descriptionShow less

Clinical practice guidelines describe sodium restriction and diuretics as first-line treatment, combined with regular body weight monitoring to assess response. In patients with suboptimal response to furosemide, alternative loop diuretics like torsemide or bumetanide may improve natriuresis. Bumetanide has a theoretic advantage over furosemide due to its more rapid and complete intestinal absorption, combined with a prolonged half-life in patients with hepatic dysfunction. In this pragmatic study, the aim is to compare the efficacy of diuresis with bumetanide versus furosemide among hospitalized patients with cirrhosis.

The 2 groups in the trial

  • BumetanideTreatment being tested
  • FurosemideTreatment being tested

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial
Plain-language title
Comparing bumetanide and furosemide water pills in hospitalized adults with cirrhosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06941415, who can take part
Record updated
16 June 2026